Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

taVNS reduces vitiligo symptoms in mice.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Male gender and family history predict alopecia areata recurrence.

Talquetamab may cause hair loss and skin issues.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

More research is needed to find the best long-term treatments for Alopecia Areata.

Cyclosporine may cause hair loss, so patients need monitoring.

Ruxolitinib treatment may cause eyelash growth.

Recent advances in hair loss treatments show significant progress.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.